You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
網譽科技(01483.HK)擬2700萬元收購上海優米泰醫療科技90%股權
格隆匯 04-08 22:12

格隆匯4月8日丨網譽科技(01483.HK)公告,於2022年4月8日,公司間接全資附屬公司航天華泰與上海仁會訂立買賣協議,據此,航天華泰有條件同意收購,而上海仁會有條件同意出售目標公司上海優米泰醫療科技有限公司的90%股權,代價總額爲人民幣2700萬元。

目標公司爲一間於中國註冊成立的有限公司。目標公司主要從事自行注射醫療器械的生產及研發。於本公佈日期,目標公司由上海仁會、吳亞金先生及王一帆先生分別直接擁有94%、5%及1%。

目標公司的筆式注射器在中國屬於二類醫療器械,並已獲得國家藥品監督管理局批準的相關認證。目標公司因符合筆式注射器的設計、開發及生產的監管要求而獲授國際標準化組織13485證書,並因其筆式注射器符合整個歐洲的產品安全要求而獲得CE全面質量保證體系證書(CE標誌)。

公司表示,目標公司主要從事自行注射醫療器械的生產及研發。筆式注射器已被患者廣泛應用於給藥,因爲其使用方便,有助於維持藥物依從性及更好地控制疾病。由於筆式注射器的便利性及便攜性使其接受度增長,董事會預計筆式注射器的需求將持續增加,並對目標公司的業務前景持樂觀態度。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account